doi:10.3389/fendo.2022.1043789 109
Instead, clinicians are entering an era where diabetes care and hepatology increasingly overlap, especially as metabolic dysfunction-associated steatotic liver disease, or MASLD, becomes Read More When GLP-1 Therapy Plateaus: What Clinicians Should Do Next May 13, 2026 Articles, Blood Glucose Control, Blood Glucose Control, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity, Type 2 Diabetes, Type 2 Diabetes 2,458 views Everything seems to be working perfectly until it suddenly isnt
Oxidation accelerates
For people who do not meet the eligibility criteria for bariatric surgery and who fail to maintain weight loss through lifestyle interventions, pharmacotherapy is the only remaining option
Buse, J.C